MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD. of Shenzhen at MEDICA 2022 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Company news



24 Aug 2022

Medcaptain Successfully Co-organised the 2022 Sino-Foreign Hospital Construction Exchange Forum

To explore the construction and high-quality development of modern hospitals in the new era, Medcaptain, alongside China Medical Equipment Association, Beijing ZYT Technology Co., Ltd. and Reed Sinopharm Exhibitions, co-organised the 2022 Sino-Foreign Hospital Construction Exchange Forum on July 23, during the 23rd China Hospital Construction Conference (CHCC) taking place at the Wuhan International Expo Center.

The forum responds positively to the development trend of hospital construction, bringing together around 200 top hospital presidents and experts from China and abroad, including Li Baoshan, Vice President and Secretary General, Hospital Architecture and Equipment Branch, China Medical Equipment Association, Yang Zhenglin, Academician of the Chinese Academy of Sciences and President of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, and Prof. Arthur Z.H. van Zanten, Medical Director of the Hospital Gelderse Vallie, the Netherlands. The experts gathered together to share their experience in hospital construction and management and interpret the core principles of high-quality hospital development from multiple perspectives, focusing on major issues such as hospital architecture planning, operation and management, equipment technology innovation, improvement of logistics operation and maintenance, and medical information system construction.

In the panel discussion, the experts focused on the topic of Strategic Planning and Implementation of High-Quality Development of Modern Hospitals and talked about how hospitals should plan for high-quality development as well as the necessary measures for implementation, offering useful suggestions. Under the guidance of the moderator Ni Qifeng, Vice President, Suzhou Municipal Hospital, the experts put forward their insightful views on the main difficulties faced by hospitals in the quality development, the top-level design of hospital construction and the factors that need to be taken into account in the implementation, as well as their views on some of today's new medical technologies and models, and shared their valuable experiences for the hospital builders present.

At this event, top hospital directors and experts from China and abroad shared their ideas and experiences in achieving milestones in the development of their hospitals, discussed with clinical workers and industry professionals on the way to high-quality hospital development, and built a broad platform for collaborative development, thus giving a strong boost to the promotion of innovative hospital construction.

The importance of academic exchange in the development of the healthcare industry cannot be overstated, and Medcaptain will continue to sponsor and co-organise such events in the future to promote the sharing of successful experiences within the industry, thus contributing to the development of the healthcare for the whole society.

More Less

28 Jul 2022

Medcaptain Exhibits at 2022 AACC with Latest In-vitro Diagnostics Innovations

On July 26-28, Medcaptain made a striking appearance with a series of main In-vitro Diagnostics products and solutions at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), held at the McCormick Place Convention Center in Chicago.

Being the world's largest conference of the in-vitro diagnostic industry, the AACC has become one of the most important international academic conferences in the field of clinical testing worldwide and has a significant international influence, attracting over 20,000 international medical professionals and medical device entrepreneurs from over 100 countries worldwide each year.

At 2022 AACC, Medcaptain showcased the cutting-edge science and technology shaping the future of laboratory medicine, including main products like the Fully-automated Chemiluminescence Immunoassay System, Real-time PCR System, Thromboelastography Analyzer, and Fully Automatic Blood Grouping Analyzer, covering coagulation, chemiluminescence, blood typing and molecular diagnostics, as well as comprehensive test items. It has attracted many visitors from around the world, capturing the much-needed disease testing business opportunities.

Medcaptain’s latest in-vitro diagnostics innovations enable clinical laboratories greater flexibility and assurance as they respond to new and existing diagnostic challenges. By minimizing hands-on time, reducing time-to-results, and improving analytical performance, Medcaptain, together with clinical users, is working toward improving patient outcomes.

Over years of operation and development, Medcaptain has won a considerable number of loyal customers in the whole world with its high-quality products and services. In the future, Medcaptain will keep advancing to meet the clinical needs, sharing more medical technologies and providing better healthcare products and solutions for society.

More Less

Please log in

You must be logged in to use matchmaking